Gilead Sciences, Inc. (GILD) Tops Q3 EPS by 4c; Raises FY13 Sales Outlook
Tweet Send to a Friend
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q3 EPS of $0.52, $0.04 better than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
